Trimethoprim/sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis

Ocular Immunology and Inflammation

Volumn 17, Issue 4, 2009, Pages 289-291

  Yazici, Alper ^a,b   Ozdal, Pinar Çakar ^a   Taskintuna, Ibrahim ^a   Kavuncu, Sevim ^a   Koklu, Gultekin ^a  

^a Ulucanlar Eye Education and Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Azithromycin; Ocular toxoplasmosis; Recurrence; Trimethoprim sulfamethoxazole; Visual acuity

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MALE; OPHTHALMOSCOPY; RECURRENT DISEASE; SCHOOL CHILD; SLIT LAMP; TOXOPLASMOSIS; TREATMENT RESPONSE; VISUAL ACUITY;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; RECURRENCE; STEROIDS; TOXOPLASMOSIS, OCULAR; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VISUAL ACUITY; YOUNG ADULT;

EID: 68849103669     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802687846     Document Type: Article

References (16)

1. Dodds EM. Ocular toxoplasmosis: Clinical presentation, diagnosis and therapy. In: Focal Points: Clinical Modules for Ophthalmologists, Vol.17. San Francisco: American Academy of Ophthalmology; 1999: 10.
2. Holland GN, O'Connor GR, Belfort R, Remington JS. Toxoplasmosis. In: People JS, Holland GN, Wilhelmus KR, eds. Ocular Infection & Immunity. St. Louis, MO: Mosby-Year Book, 1996: 1083-1223.
3. Dodds EM. Toxoplasmosis. Curr Opin Ophthalmol. 2006; 17: 557-561.
4. Rothova A, Bosch-Driessen LE, van Loon NH, Treffers WF. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol. 1998; 82: 1306-1308.
5. Rothova A, Meenken C, Buitenhuis HJ, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993; 115: 517-523.
6. Opremcak EM, Scales DK, Sharpe MR. Trimethoprimsulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology. 1992; 99: 920-925.
7. Huskinson-Mark J, Araujo FG, Remington JS. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis. 1991; 164: 170-171.
8. Silveira C, Belfort R Jr, Muccioli C, et al. The effect of longterm intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002; 134: 41-46. (Pubitemid 34722708)
9. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996; 121: 35-46.
10. SoheilianM, Heidari K, Yazdani S, ShahsavariM, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004; 12: 297-310. (Pubitemid 40138186)
11. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002; 134: 102-114. (Pubitemid 34722718)
12. Acers TE. Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol. 1964; 71: 58-62.
13. Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology. 2003; 110: 926-931. (Pubitemid 36560490)
14. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002; 109: 869-878. (Pubitemid 34465218)
15. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MSA, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002; 134: 34-40.
16. Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis. 1996; 22: 268-275. (Pubitemid 26056155)